Print Page

Products found to contain undeclared medicines

The United States: Issues Voluntary Nationwide Recall of Silver Sword and Clalis at the Request of the FDA as the products have been found to contain sildenafil
Upon request of the Food and Drug Administration (FDA), is voluntarily recalling 430 lots of Silver Sword and Clalis at the consumer level. According to representatives of the FDA, Silver Sword and Clalis have reportedly been found to contain amounts of PDE-5 Inhibitor Sildenafil, which could cause adverse reactions and drug interactions normally associated with the active ingredient in Viagra. These products are intended to be used as a dietary supplement and sexual supplement. Silver Sword is packaged in a tin containing 8 doses, 2 pills per dose. Clalis is packaged in box containing a bottle of 6 pills. According to the FDA report, the affected Silver Sword and Clalis lots include those produced on or before April 2, 2013. The production date is stamped on the back of the packaging. Silver Sword can be identified by the tan and red tin labeled as Silver Sword. Clalis can be identified by its distinctive blue box. It is recommended that consumers and retailers that have the Silver Sword or Clalis supplements should stop using this product immediately, and contact a doctor if any of the side effects have been felt.

Please refer to the following website in FDA for details:

In Hong Kong, the above products are not registered pharmaceutical products. Related news has been released by FDA and was posted on the Drug Office website on 28 June and 29 June 2013.

Ends/ Tuesday, July 16, 2013
Issued at HKT 12:00